A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...

Shares of Allurion Technologies Inc (NYSE:ALUR) climbed 2.9% after the company announced a strategic distribution partnership with Canadian medical device firm Minogue Medical Inc., which specializes ...